ArticleCancer immunology, immunotherapy : CII2011

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.

Brian M Olson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.